Caris (CAI) Director Laura Johansen Receives 13,192-Share Award

What Happened

• Laura I. Johansen, a director of Caris Life Sciences (CAI), received an award of 13,192 restricted stock units (RSUs) on 2026-08-14. The Form 4 reports an acquisition price of $0.00 (typical for RSU grants), so the reported cash value at grant is $0.00. These RSUs represent the right to receive shares if and when they vest under the grant agreement.

Key Details

• Transaction date: 2026-08-14; Transaction type: Award/Grant (code A).
• Shares/units granted: 13,192 RSUs; reported acquisition price: $0.00.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: Awarded RSUs vest according to the applicable grant agreement (see footnote F1).
• Filing timeliness: Reported on 2026-08-14 (no late filing indicator provided).

Context

• RSUs are a form of equity compensation that vest over time or upon achievement of conditions; they are not an immediate cash purchase or sale and only convert into actual shares when vested.
• Such grants are common for directors and serve as compensation/alignment with shareholders; they should not be interpreted alone as a buy or sell signal.